Lipid News

The state of the lipid research community — improving grant review

Binks Wattenberg
March 1, 2018

I have just returned from Washington, D.C., where I was on a National Institutes of Health study section. I am happy to report that the state of the lipid research community is excellent. But it always can be better, particularly when getting our grants reviewed, and that is a prime focus of the American Society for Biochemistry and Molecular Biology’s Lipid Research Division, or LRD.

National Institutes of Health study sessions meet at the main NIH campus in Bethesda, Maryland, shown in this aerial photo.NIH photo

The underlying premise of a new LRD initiative is that grants with a lipid focus suffer when study sections do not have sufficient lipid-centric reviewers. Although the scientific review officers, or SROs, work to get relevant expertise on the panels, several have told me they sometimes struggle to find lipid reviewers. We need individuals on these panels who can put the lipid work into context for the other study section members. Toward this end, we have an ongoing effort to improve the review of lipid-related grants by identifying qualified reviewers with lipid expertise. This has been a three-phase effort.

First, early last year we reached out to the ASBMB membership to encourage members involved in lipid research to join the LRD if they had not done so already. This has swelled the ranks of the division, and we are now 640 members strong.

The second phase was a survey sent out to the LRD membership to capture the review experience and research expertise of each member. The response? Not bad, but could be better. Out of the total membership, 348 received the survey. (Why not all? Explanation below.) Of those, we received 143 responses — an outstanding response rate for this kind of survey request. The survey identified 46 individuals who have NIH reviewing experience, which is the strong preference of the SROs, and an additional eight U.S.-based researchers with non-NIH reviewing experience. Those individuals might be recruited by SROs to increase the ranks of reviewers.

In the third phase, the results of the survey, in spreadsheet form, are now being distributed to SROs of study sections that historically have handled grants from the LRD membership. The SROs’ responses have been very enthusiastic. Finding qualified reviewers with the right expertise is one of their most time-consuming challenges. They definitely will use our results.

We know there are more qualified reviewers out there, and the SROs would love to have them serve on their panels. So rather than the usual kvetching around the bar about the terrible review your lipid grant received, here is how you can help. First, if you do lipid research and are not an LRD member, join here. Second, only a little more than half of the LRD membership received the survey, because many of you have asked not to receive e-mails from the ASBMB. We have no way to reach you. Please consider changing this in your profile so we can get in touch.

While the state of our community is strong in many ways, the fate of lipid grants is in your hands, in more ways than one. Help us to help you.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Binks Wattenberg

Binks Wattenberg is a professor in the department of biochemistry and molecular biology at Virginia Commonwealth University and a member of the ASBMB Today editorial advisory board.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.

Animals have used bioluminescence to communicate for millions of years
News

Animals have used bioluminescence to communicate for millions of years

July 13, 2024

Despite its widespread occurrence, scientists don’t yet know when or where this phenomenon first emerged, or its original function.

Getting to the genetic basis of cardiovascular disease
Journal News

Getting to the genetic basis of cardiovascular disease

July 11, 2024

Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.

Microparticles safeguard vitamins and information
News

Microparticles safeguard vitamins and information

July 9, 2024

Scientists aim to use nanotechnology to combat malnutrition and improve medical recordkeeping in impoverished parts of the world.

Why AlphaFold 3 needs to be open source
Essay

Why AlphaFold 3 needs to be open source

July 7, 2024

The powerful AI-driven software from DeepMind was released without making its code openly available to scientists.

Summertime can be germy
Advice

Summertime can be germy

July 6, 2024

A microbiologist explains how to avoid getting sick at the barbecue, in the pool or on the trail.